Appia Bio has emerged from stealth with $52m in series A financing to commercialise cancer treatments based on research at UCLA.

Bertelsmann helped crypto financial service provider Babel Finance close a $40m series A round while Blind raised $37m from investors including Cisco.

CSAA-backed digital home insurance provider Kin secured $63.9m to increase its overall funding to about $150m.

UChicago once again invested in Kin Insurance, participating in a $63.9m series C round that brought its overall funding to nearly $150m.

The autonomous driving technology developer is looking to ramp up production with capital from investors including Nio and Bertelsmann.

The Sinopharm-backed oncology drug developer has raised series D1 funding in a round led by China Structural Reform Fund Corporation.

The e-commerce software provider received funding in a round led by Sinar Mas subsidiary SMDV at a reported $116m valuation.

The photonic computing technology spinout of MIT has now pocketed $113m in funding altogether.

Lilly Asia Ventures was among the investors in a series B round for the renal disease treatment developer, which it incubated in 2018.

Alphabet, Hewlett Packard Enterprise and Lockheed Martin invested in the photonic computing technology developer’s series B round, increasing its total funding to $113m.